TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,812,041 | +1.7% | 48,052 | +2.3% | 0.00% | – |
| Q2 2023 | $1,781,155 | +444.6% | 46,959 | +249.2% | 0.00% | – |
| Q1 2023 | $327,032 | -16.2% | 13,447 | +0.1% | 0.00% | – |
| Q4 2022 | $390,211 | -5.1% | 13,437 | -2.2% | 0.00% | – |
| Q3 2022 | $411,000 | -17.3% | 13,737 | 0.0% | 0.00% | – |
| Q2 2022 | $497,000 | -11.9% | 13,737 | +5.4% | 0.00% | – |
| Q1 2022 | $564,000 | -3.1% | 13,037 | +12.3% | 0.00% | – |
| Q4 2021 | $582,000 | -18.5% | 11,604 | +3.4% | 0.00% | – |
| Q3 2021 | $714,000 | -11.5% | 11,223 | 0.0% | 0.00% | – |
| Q2 2021 | $807,000 | -20.1% | 11,223 | -18.1% | 0.00% | – |
| Q1 2021 | $1,010,000 | +18.0% | 13,707 | +17.6% | 0.00% | – |
| Q4 2020 | $856,000 | +225.5% | 11,657 | +142.6% | 0.00% | – |
| Q3 2020 | $263,000 | -17.3% | 4,806 | +0.5% | 0.00% | – |
| Q2 2020 | $318,000 | +18.2% | 4,781 | +9.0% | 0.00% | – |
| Q1 2020 | $269,000 | -27.9% | 4,388 | +3.5% | 0.00% | – |
| Q4 2019 | $373,000 | +19.2% | 4,239 | +2.1% | 0.00% | – |
| Q3 2019 | $313,000 | -12.1% | 4,153 | -0.1% | 0.00% | – |
| Q2 2019 | $356,000 | -18.5% | 4,159 | +2.8% | 0.00% | – |
| Q1 2019 | $437,000 | +32.0% | 4,046 | +3.3% | 0.00% | – |
| Q4 2018 | $331,000 | -12.7% | 3,916 | +1.6% | 0.00% | – |
| Q3 2018 | $379,000 | -15.0% | 3,854 | 0.0% | 0.00% | – |
| Q2 2018 | $446,000 | +18.3% | 3,854 | +1.0% | 0.00% | – |
| Q1 2018 | $377,000 | -5.5% | 3,814 | 0.0% | 0.00% | – |
| Q4 2017 | $399,000 | -86.3% | 3,814 | -85.3% | 0.00% | – |
| Q3 2017 | $2,916,000 | +0.5% | 25,892 | 0.0% | 0.00% | – |
| Q2 2017 | $2,901,000 | -15.7% | 25,892 | -12.2% | 0.00% | – |
| Q1 2017 | $3,440,000 | +34.9% | 29,500 | +21.8% | 0.00% | – |
| Q4 2016 | $2,550,000 | -8.8% | 24,222 | -4.3% | 0.00% | – |
| Q3 2016 | $2,797,000 | -24.1% | 25,308 | 0.0% | 0.00% | – |
| Q2 2016 | $3,685,000 | +146.5% | 25,308 | +142.4% | 0.00% | – |
| Q1 2016 | $1,495,000 | -3.9% | 10,439 | +3.7% | 0.00% | – |
| Q4 2015 | $1,556,000 | +395.5% | 10,071 | +357.8% | 0.00% | – |
| Q3 2015 | $314,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |